Recombinant Human TGFBR3/ Betaglycan protein (His tag)

Recombinant Human TGFBR3/ Betaglycan protein (His tag)
SKU
ELSPDEH100270-100
Packaging Unit
100 µg
Manufacturer
Elabscience Biotechnology

Availability: loading...
Price is loading...
Abbreviation: TGFBR3;Betaglycan

Target Synonym: BGCAN

Target Species: Human

Expression Host: E.coli

Fusion Tag: N-His

UNIProt ID: Q03167

Background: Betaglycan also known as transforming growth factor beta receptor III (TGFBR3), is a cell-surface chondroitin sulfate / heparan sulfate proteoglycan. TGFBR3 is a transforming growth factor (TGF)-beta type III receptor. This receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. TGFBR3 is the TGF-β component most commonly downregulated among localized human prostate cancer studies. TGFBR3 knockdown led to focus formation and enhanced expression of CD133, a marker found on prostate cancer stem cells. TGFBR3 is an accessory receptor that binds to and modulates the activities of both transforming growth factor-beta (TGFβ) and inhibin, two members of the TGFβ superfamily of growth factors that regulate many aspects of reproductive biology. TGFBR3 is known to be expressed in adult testis and ovary, but little is known about this receptor during gonadogenesis.

Sequence: Gln 526-Thr 787

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Endotoxin: Please contact us for more information.
More Information
SKU ELSPDEH100270-100
Manufacturer Elabscience Biotechnology
Manufacturer SKU ELA-PDEH100270-100
Package Unit 100 µg
Quantity Unit STK
Product information (PDF) Download
MSDS (PDF) Download